이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery

2026년 11월 16일 업데이트: Mustafa Kemal ŞAHİN, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Association of Preoperative Sleep Quality With 24-Hour Systemic Immune-Inflammation Index, Early PACU Pain, and Analgesic Use After Breast Cancer Surgery

This prospective, single-center observational study examined the association between preoperative sleep quality and postoperative outcomes in women undergoing elective breast cancer surgery. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), with scores ≤5 indicating good sleep quality and scores >5 indicating poor sleep quality.

The primary outcome was the systemic immune-inflammation index (SII), calculated from routine blood counts obtained 24 hours after surgery. Postoperative SII was compared between sleep-quality groups, accounting for preoperative SII and relevant clinical and surgical characteristics. Secondary outcomes included change in SII from baseline, pain intensity during the first 45 minutes in the post-anesthesia care unit (PACU), opioid consumption, rescue analgesic requirement, and length of hospital stay. Pain was assessed using a 10-cm visual analogue scale on PACU arrival and at 15, 30, and 45 minutes. Opioid consumption included morphine and tramadol administered during the final 20 minutes of surgery and the first 45 minutes in the PACU, expressed as intravenous morphine equivalents.

No treatment was assigned by the study protocol. Anesthetic and analgesic management followed routine clinical practice.

연구 개요

상세 설명

This prospective observational study was conducted at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital in Ankara, Turkey, among women undergoing elective breast cancer surgery under general anesthesia. Procedures included lumpectomy or mastectomy, with axillary dissection when clinically indicated. The study examined whether preoperative sleep quality was associated with postoperative systemic immune-inflammation index (SII), immediate postoperative pain, and analgesic use.

Preoperative sleep quality was assessed using the validated Turkish version of the Pittsburgh Sleep Quality Index (PSQI). The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality. Patients were classified as having good sleep quality (PSQI ≤5) or poor sleep quality (PSQI >5). Demographic characteristics, comorbidities, oncological history, surgical characteristics, and perioperative clinical data were recorded prospectively.

The primary outcome was SII measured 24 hours (±6 hours) after surgery, calculated as platelet count × neutrophil count / lymphocyte count. Preoperative SII was calculated using the same formula. The primary analysis compared postoperative SII between sleep-quality groups, adjusting for baseline SII and clinical and surgical covariates. Change in SII, calculated as postoperative minus preoperative SII, was a secondary outcome.

Pain intensity was assessed using a 10-cm visual analogue scale (VAS), anchored at "no pain" and "worst imaginable pain." Patients marked their pain intensity on the line; the distance from the zero anchor was measured and rounded to the nearest whole centimeter. Assessments were performed on arrival in the post-anesthesia care unit (PACU) and at 15, 30, and 45 minutes. Maximum VAS was defined as the highest score across the four scheduled assessments. The pain assessor was unaware of patients' PSQI scores and sleep-quality groups.

Anesthetic and analgesic management followed routine clinical practice, with no treatment assigned by the study protocol. Intravenous morphine or tramadol was administered for postoperative analgesia during the final 20 minutes of surgery. Rescue analgesia consisted of intravenous morphine or tramadol when the PACU VAS score was ≥4; drug selection and dosing were determined by the treating anesthesiologist. Scheduled pain assessments continued after rescue treatment. No regional blocks or surgical local anesthetic infiltration were performed.

Total opioid consumption comprised morphine and tramadol administered during the final 20 minutes of surgery and the first 45 minutes in the PACU. Intravenous tramadol doses were converted to intravenous morphine equivalents using a factor of 0.1 and added to the administered morphine dose. Fentanyl used for induction and remifentanil used for maintenance were excluded from this measure. Rescue analgesic requirement was defined as receipt of at least one rescue opioid dose during the PACU observation period. The planned 24-hour pain and opioid outcomes could not be reliably evaluated because of follow-up limitations and incomplete opioid documentation. The reported analyses were therefore restricted to PACU pain during the first 45 minutes and opioid administration during the final 20 minutes of surgery and this PACU period. Length of hospital stay was also recorded.

Secondary analyses evaluated PSQI total score as a continuous predictor of postoperative SII, maximum VAS, total opioid consumption, and rescue analgesic requirement. Adjustment variables included age, body mass index, ASA physical status III, chronic disease burden, chemotherapy within the previous year, axillary dissection, and operation duration. Breast surgery type was added to the models during manuscript revision. Preoperative SII was included only in the postoperative SII models. Individual covariate-outcome associations were interpreted as exploratory.

연구 유형

관찰

등록 (실제)

156

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Ankara, 터키 (Türkiye), 06200
        • Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Reanimation

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

여성

샘플링 방법

비확률 샘플

연구 인구

The study population included women aged 18-75 years who underwent elective breast cancer surgery at a tertiary oncology center. Procedures included breast-conserving surgery (lumpectomy) or mastectomy, with or without axillary dissection. Preoperative sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). All patients received routine perioperative care, and no treatment was assigned by the study protocol. This observational study examined the association between preoperative sleep quality and postoperative outcomes in routine clinical practice.

설명

Inclusion Criteria:

  • Female patients aged 18 to 75 years
  • Scheduled for elective breast cancer surgery
  • American Society of Anesthesiologists (ASA) physical status I to III
  • Able to understand and complete the Pittsburgh Sleep Quality Index (PSQI)
  • Willing to participate in the study
  • Provided written informed consent

Exclusion Criteria:

  • Active infection
  • History of chronic inflammatory disease or autoimmune disease
  • Use of steroids or immunosuppressive drugs within the past 6 months
  • Known diagnosis of obstructive sleep apnea syndrome
  • Severe cognitive impairment preventing completion of the questionnaire
  • Planned emergency surgery
  • Refusal to participate or failure to provide informed consent

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

코호트 및 개입

그룹/코호트
개입 / 치료
Good Sleep Quality (PSQI ≤ 5)

Patients with good preoperative sleep quality, defined as a Pittsburgh Sleep Quality Index (PSQI) score ≤5, were included in this cohort. Sleep quality was assessed preoperatively using the validated PSQI questionnaire. No treatment was assigned by the study protocol, and patients received routine perioperative care. Postoperative SII, pain intensity, and analgesic consumption were compared with those in the poor-sleep-quality group.

Preoperative sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a validated self-reported questionnaire covering the preceding month. Patients were classified into two cohorts: good sleep quality (PSQI ≤5) and poor sleep quality (PSQI >5). The PSQI assessment was used for grouping and analysis. No treatment was assigned by the study protocol, and perioperative management followed routine clinical practice.

다른 이름들:
  • 피츠버그 수면 질 지수(PSQI)
Poor Sleep Quality (PSQI > 5)

Patients with poor preoperative sleep quality, defined as a Pittsburgh Sleep Quality Index (PSQI) score >5, were included in this cohort. Sleep quality was assessed preoperatively using the validated PSQI questionnaire. No treatment was assigned by the study protocol, and patients received routine perioperative care. Postoperative SII, pain intensity, and analgesic consumption were compared with those in the good-sleep-quality group.

Preoperative sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a validated self-reported questionnaire covering the preceding month. Patients were classified into two cohorts: good sleep quality (PSQI ≤5) and poor sleep quality (PSQI >5). The PSQI assessment was used for grouping and analysis. No treatment was assigned by the study protocol, and perioperative management followed routine clinical practice.

다른 이름들:
  • 피츠버그 수면 질 지수(PSQI)

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Postoperative Systemic Immune-Inflammation Index (SII)
기간: At 24 hours postoperatively (± 6 hours)

The primary outcome was the postoperative systemic immune-inflammation index (SII), calculated from routine complete blood count measurements obtained 24 hours after surgery. SII was calculated using the formula: platelet count × neutrophil count / lymphocyte count. Postoperative SII was compared between patients with poor (PSQI >5) and good (PSQI ≤5) preoperative sleep quality, adjusting for preoperative SII and clinical and surgical covariates.

At 24 hours postoperatively (± 6 hours)

2차 결과 측정

결과 측정
측정값 설명
기간
Change in Systemic Immune-Inflammation Index (ΔSII)
기간: From the preoperative assessment to 24 hours after surgery.

Change in SII was calculated as postoperative SII minus preoperative SII. SII was calculated at both time points as platelet count × neutrophil count / lymphocyte count. Changes were compared between patients with good (PSQI ≤5) and poor (PSQI >5) preoperative sleep quality.

From the preoperative assessment to 24 hours after surgery.
Immediate Postoperative Pain Intensity
기간: On arrival in the post-anesthesia care unit (0 minutes) and at 15, 30, and 45 minutes after arrival.

Pain intensity was assessed using a 10-cm visual analogue scale (VAS), anchored at 0 cm ("no pain") and 10 cm ("worst imaginable pain"). Patients marked their pain intensity on the line, and the measured distance was rounded to the nearest whole centimeter. Scores were recorded at each scheduled assessment, including after rescue analgesia when applicable. Maximum VAS was defined as the highest score across the four assessments

On arrival in the post-anesthesia care unit (0 minutes) and at 15, 30, and 45 minutes after arrival.
Total Opioid Consumption for Postoperative Analgesia
기간: From 20 minutes before the end of surgery through the first 45 minutes after PACU arrival.

Total opioid consumption was calculated as the sum of intravenous morphine and tramadol administered for postoperative analgesia during the final 20 minutes of surgery and the first 45 minutes in the post-anesthesia care unit (PACU), including rescue doses. Tramadol doses were multiplied by 0.1 to obtain intravenous morphine equivalents and added to the morphine dose. Consumption was expressed in milligrams of intravenous morphine equivalents. Fentanyl administered during induction and remifentanil used for maintenance were excluded.

From 20 minutes before the end of surgery through the first 45 minutes after PACU arrival.
Rescue Analgesic Requirement
기간: Within the first 45 minutes after arrival in the post-anesthesia care unit.

Rescue analgesic requirement was defined as receipt of at least one intravenous dose of morphine or tramadol during the first 45 minutes in the post-anesthesia care unit (PACU). Rescue analgesia was administered when the visual analogue scale (VAS) score was ≥4. Drug selection and dosing were determined by the anesthesiologist responsible for PACU care. The outcome was recorded as yes/no and summarized as the number and percentage of patients receiving rescue analgesia.

Within the first 45 minutes after arrival in the post-anesthesia care unit.
Postoperative Length of Hospital Stay
기간: From the date of surgery until hospital discharge, assessed up to 15 days after surgery.

Postoperative length of hospital stay was defined as the duration from the day of breast cancer surgery to hospital discharge, measured in days.

From the date of surgery until hospital discharge, assessed up to 15 days after surgery.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 4월 17일

기본 완료 (실제)

2026년 8월 20일

연구 완료 (실제)

2026년 8월 30일

연구 등록 날짜

최초 제출

2026년 4월 17일

QC 기준을 충족하는 최초 제출

2026년 4월 17일

처음 게시됨 (실제)

2026년 4월 23일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 16일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

Individual participant data (IPD) will not be shared. The study involves sensitive clinical data collected from patients in a single-center setting, and data sharing is restricted in order to protect patient confidentiality and comply with institutional and ethical regulations.

De-identified and aggregated data may be available from the corresponding author upon reasonable request, subject to approval by the institutional ethics committee.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다